News

April 3, 2020April 3, 2020

Winners Named for Prostate Cancer Foundation’s TRUE Love Awareness Contest

News

The 3rd annual TRUE Love Contest of the Prostate Cancer Foundation (PCF), which features inspirational stories from patients and caregivers to raise disease awareness, has selected two winners. Chosen ... Read more

March 27, 2020March 27, 2020

Guidelines for Radiation Therapy with COVID-19 Urge Less Treatment

News

New guidelines for radiation oncologists suggest that, during the COVID-19 pandemic, interactions with healthcare professionals should be done remotely where possible, and treatments should be avoided or delayed to minimize ... Read more

March 23, 2020March 23, 2020

Combining Two Biopsy Methods Improves PC Diagnosis, Study Shows

News

Combining two methods of prostate biopsy — using one guided by magnetic resonance imaging (MRI) along with conventional ultrasound-guided biopsy — results in a more accurate detection of clinically ... Read more

March 19, 2020March 23, 2020

Urine Biomarkers Can Be Used to Develop Test for Prostate Cancer, Study Finds

News

Patients with prostate cancer exhibit changes in the levels of some urinary molecules compared with people with benign prostate diseases and healthy individuals, a study found, suggesting that these ... Read more

March 18, 2020March 18, 2020

Proscia and UCSF Partnering to Deliver AI Apps to Improve Cancer Diagnosis

News

Proscia and the University of California San Francisco (UCSF) are partnering to use artificial intelligence (AI) to improve the accuracy and speed of cancer diagnoses, starting with prostate cancer. ... Read more

March 16, 2020March 23, 2020

Veru Advances Prostate Cancer Therapy VERU-111 to Phase 2 Portion of Trial

News

Veru said it initiated the Phase 2 portion of a clinical trial testing the safety and effectiveness of its investigational therapy, VERU-111, in men with metastatic castration-resistant prostate cancer ... Read more

March 12, 2020March 12, 2020

Adoptive Cell Therapy Can Slow Prostate Cancer Growth, Study in Mice Reports

News

Treating prostate cancer animal models with modified immune cells that were isolated from bone marrow led to a significant reduction in tumor growth, a study in mice reports. These ... Read more

March 11, 2020March 23, 2020

Ciforadenant Has Promising Anti-tumor Activity in mCRPC, Early Data Show

News

Treatment with Corvus Pharmaceuticals‘ ciforadenant (CPI-444), alone or in combination with Tecentriq (atezolizumab), is well tolerated and showed promising anti-tumor activity in heavily pretreated metastatic castration-resistant prostate cancer (mCRPC) patients, ... Read more

March 9, 2020March 9, 2020

Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds

News

Myriad Genetics’ Prolaris — a genetic test that predicts the aggressiveness of prostate cancer — can identify which men with intermediate or high-risk prostate cancer will benefit from combining ... Read more

March 6, 2020March 12, 2020

3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows

News

The bioscience company miR Scientific has presented breakthrough data on three urine-based tests to detect and classify prostate cancer from RNA molecules, called small non-coding RNAs (sncRNAs). The first ... Read more

Pin It on Pinterest